These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3373163)

  • 1. Correlation of plasma concentration and effects of succinylcholine in dogs.
    Baldwin KA; Forney R
    J Forensic Sci; 1988 Mar; 33(2):470-9. PubMed ID: 3373163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between cardiac output and onset of succinylcholine chloride action in electroconvulsive therapy patients.
    Matsumoto N; Tomioka A; Sato T; Kawasaki M; Kadoi Y; Saito S
    J ECT; 2009 Dec; 25(4):246-9. PubMed ID: 19252443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of storage temperature and chemical preservation on the stability of succinylcholine in canine tissue.
    Baldwin KA; Forney R
    J Forensic Sci; 1988 Mar; 33(2):462-9. PubMed ID: 3373162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic properties of succinylcholine in greyhounds.
    Curtis MB; Eicker SE
    Am J Vet Res; 1991 Jun; 52(6):898-902. PubMed ID: 1883092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lidocaine modifies the effect of succinylcholine on muscle oxygen consumption in dogs.
    Fukuda S; Wakuta K; Ishikawa T; Oshita S; Sakabe T; Takeshita H
    Anesth Analg; 1987 Apr; 66(4):325-8. PubMed ID: 3565794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacologic effects of the S(-) isomer of bupivacaine after intravenous and epidural administration in dogs.
    Franquelo C; Toledo A; Manubens J; Valladares JE; Cristòfol C; Arboix M
    Am J Vet Res; 1999 Jul; 60(7):832-5. PubMed ID: 10407475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular blocking effects of tobramycin, gentamicin, and cefazolin.
    Lippmann M; Yang E; Au E; Lee C
    Anesth Analg; 1982 Sep; 61(9):767-70. PubMed ID: 7201757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of succinylcholine on neuromuscular transmission during recovery from vecuronium].
    Miyamoto M; Hirai H; Fujimoto K; Yurino M; Ogawa H
    Masui; 1994 Apr; 43(4):487-91. PubMed ID: 7910644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic variables of mivacurium chloride after intravenous administration in dogs.
    Smith LJ; Schwark WS; Cook DR; Moon PF; Looney AL
    Am J Vet Res; 1999 Sep; 60(9):1051-4. PubMed ID: 10490070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular blocking drug pharmacodynamics after chronic exposure to H2- antagonists.
    Rana J; Ramzan I
    In Vivo; 1995; 9(2):163-6. PubMed ID: 7548793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of succinylcholine-produced phase II neuromuscular block during enflurane, halothane, and fentanyl anesthesia.
    Hilgenberg JC; Stoelting RK
    Anesth Analg; 1981 Apr; 60(4):192-6. PubMed ID: 7193996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency of succinylcholine at the diaphragm and at the adductor pollicis muscle.
    Smith CE; Donati F; Bevan DR
    Anesth Analg; 1988 Jul; 67(7):625-30. PubMed ID: 3382036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular interactions between succinylcholine and esmolol in the rat.
    Chang RY; Chern SC; Chiang YY; Liou MD; Tseng KF; Tsai SK
    Acta Anaesthesiol Sin; 1994 Sep; 32(3):203-8. PubMed ID: 7921866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of succinylcholine on the recovery of block produced by mivacurium in rats.
    Kanyamibwa D; Tsaousi G; Karakoulas K; Thomareis O; Parlapani A; Makedou AH; Giala M
    Methods Find Exp Clin Pharmacol; 2008 Apr; 30(3):187-91. PubMed ID: 18597002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of 4-aminopyridine in anesthetized dogs.
    Rupp SM; Shinohara Y; Fisher DM; Miller RD; Castagnoli N
    J Pharmacol Exp Ther; 1983 May; 225(2):351-4. PubMed ID: 6842398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tachyphylaxis and phase II block development during infusion of succinylcholine in children.
    DeCook TH; Goudsouzian NG
    Anesth Analg; 1980 Sep; 59(9):639-43. PubMed ID: 7191220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
    Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK
    Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of succinylcholine in man.
    Hoshi K; Hashimoto Y; Matsukawa S
    Tohoku J Exp Med; 1993 Aug; 170(4):245-50. PubMed ID: 8122251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, effects on renal function, and potentiation of atracurium-induced neuromuscular blockade after administration of a high dose of gentamicin in isoflurane-anesthetized dogs.
    Martinez EA; Mealey KL; Wooldridge AA; Mercer DE; Cooper J; Slater MR; Hartsfield SM
    Am J Vet Res; 1996 Nov; 57(11):1623-6. PubMed ID: 8915441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.